Main non-standardized medicines and the financial impact on their purchase in a teaching hospital in the northern ceará zone
International Journal of Development Research
Main non-standardized medicines and the financial impact on their purchase in a teaching hospital in the northern ceará zone
Received 18th December, 2018; Received in revised form 11th January, 2019; Accepted 20th February, 2019; Published online 29th March, 2019
Copyright © 2019, Letícia Bandeira Mascarenhas Lopes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction: In the hospital, the pharmacy aims to ensure the safe and rational use of medicines that will be prescribed by the doctor through a planning in the purchase of medicines and hospital materials. Only the products included in the list of standardized drugs are purchased in a programmed manner by the hospital and are available for use. Materials and methods: This is a descriptive, observational, exploratory, retrospective study of a quantitative approach. Results: It was observed that in both years of our study that non-standardized drugs most consumed are not necessarily the highest financial values. Discussion: of the 1,590 prescriptions that arrived at the pharmacy of a teaching hospital in Rio Grande do Norte, 313 were related to non-standard medications. Of these, the same requests of our study were: anti-inflammatory (15.65%), neuroleptic (14.78%), antiepileptic (9.57%), antimycotic (6.96%). Conclusion: Among the purchase requests sent to the hospital pharmacy, it was possible to identify that in both years of our study, the most commonly used non-standardized medications are not necessarily the ones with the highest financial values. Taking Linezolina 600 mg in both 2015-2016 and 2016-2017 the highest value drug purchased.
